| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/26/1998 | WO1998007320A1 NEUTRALIZATION-SENSITIVE EPITOPES OF $i(CRYPTOSPORIDIUM PARVUM) |
| 02/26/1998 | WO1998003200A3 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 02/26/1998 | WO1998002546A3 Dna immunization against chlamydia infection |
| 02/26/1998 | WO1998001570A3 Mutated antibody-dependent infection enhancing domains of hiv |
| 02/26/1998 | WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/26/1998 | DE19648962C1 DNA encoding peptide(s) from papilloma virus major capsid protein |
| 02/26/1998 | DE19633731A1 Hybrid cells used as anti-cancer vaccine |
| 02/26/1998 | DE19633698A1 Neue Systeme zur Regulation der Genexpression New systems for the regulation of gene expression |
| 02/26/1998 | CA2264200A1 Human endokine alpha |
| 02/26/1998 | CA2263894A1 Novel human growth factors |
| 02/26/1998 | CA2263890A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 02/26/1998 | CA2263854A1 Don-1 gene and polypeptides and uses therefor |
| 02/26/1998 | CA2263832A1 T1 receptor-like ligand ii |
| 02/26/1998 | CA2263830A1 T1 receptor-like ligand i |
| 02/26/1998 | CA2263141A1 Neutralization-sensitive epitopes of cryptosporidium parvum |
| 02/26/1998 | CA2232239A1 Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast |
| 02/25/1998 | EP0825260A2 Arginase II |
| 02/25/1998 | EP0825256A2 Hybrid cell and its use for the preparation of a drug for the induction of tumourimmunity |
| 02/25/1998 | EP0824699A2 Compounds and methods for diagnosis of leishmaniasis |
| 02/25/1998 | EP0824594A1 Improved methods for transfecting t cells |
| 02/25/1998 | EP0824590A1 Vasoactive intestinal peptide |
| 02/25/1998 | EP0824548A1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits |
| 02/25/1998 | EP0824360A1 Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins |
| 02/25/1998 | EP0824359A1 Peptide-based vaccine against papillomavirus infection |
| 02/25/1998 | EP0824358A1 Acellular pertussis vaccines and methods of preparation thereof |
| 02/25/1998 | CN1174559A Major outer membrane protein CD of Moraxella |
| 02/25/1998 | CN1174508A Improvement in or relating to endometrial function |
| 02/25/1998 | CN1174507A Antitumor agent potentiator comprising IL-6 antagonist |
| 02/25/1998 | CN1174082A Method of using active peptide in strengthening animal's immunity and as vaccine adjuvant |
| 02/24/1998 | US5721354 For treatment of infections, medical diagnosis |
| 02/24/1998 | US5721351 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/24/1998 | US5721349 Genetically altered mutant strain |
| 02/24/1998 | US5721348 DNA encoding PH-20 proteins |
| 02/24/1998 | US5721339 For identifying and quantifying native antigens on pathogenic bacteria in clinical specimens |
| 02/24/1998 | US5721337 Human thymosin β15 |
| 02/24/1998 | US5721215 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 02/24/1998 | US5721211 Compositions and methods for treating small cell and nonsmall cell lung cancers |
| 02/24/1998 | US5721122 Obtaining lymphocytes |
| 02/24/1998 | US5721119 Nucleic acid sequences |
| 02/24/1998 | US5721115 Genetic engineering |
| 02/24/1998 | US5721110 Reacting autoimmune antigen (from genetically engineered cells) with autoimmune antibody(from test sample) to form a complex which can be identified |
| 02/24/1998 | US5721108 Capable of mediating antibody-dependent cellular cytotoxicity or complement-dependent cytolysis |
| 02/24/1998 | US5721107 Antibodies to G protein coupled glutamate receptors |
| 02/24/1998 | US5720959 Malaria vaccine |
| 02/24/1998 | US5720957 Recombinant human cytomegalovirus vaccine |
| 02/24/1998 | US5720955 Method of treating rheumatoid arthritis with soluble collagen |
| 02/24/1998 | US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor |
| 02/24/1998 | US5720937 In vivo tumor detection assay |
| 02/24/1998 | CA1339681C Method for contraception by immunization against the zona pellucida |
| 02/23/1998 | CA2183901A1 Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans |
| 02/23/1998 | CA2183900A1 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans |
| 02/19/1998 | WO1998006861A2 Delivery of tolerogenic antigens via edible plants or plant-derived products |
| 02/19/1998 | WO1998006853A1 Treatment and prevention of helicobacter infection |
| 02/19/1998 | WO1998006851A2 DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF $i(MORAXELLA CATARRHALIS) |
| 02/19/1998 | WO1998006850A1 Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines |
| 02/19/1998 | WO1998006848A1 GnRH-LEUKOTOXIN CHIMERAS |
| 02/19/1998 | WO1998006842A1 Mammalian cell surface antigens; related reagents |
| 02/19/1998 | WO1998006841A2 Two human nsp-like proteins |
| 02/19/1998 | WO1998006838A1 Methods and means for modifying complement activation |
| 02/19/1998 | WO1998006830A1 Synthetic polynucleotides |
| 02/19/1998 | WO1998006746A2 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
| 02/19/1998 | WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/19/1998 | WO1998006733A1 Nucleotide sequence encoding the cd33-like protein |
| 02/19/1998 | WO1998006441A1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
| 02/19/1998 | WO1998006434A1 METHOD OF AUGMENTING T CELL-MEDIATED IMMUNITY AGAINST $i(TOXOPLASMA GONDII) |
| 02/19/1998 | WO1998006432A1 Outer membrane protein b1 of moraxella catarrhalis |
| 02/19/1998 | WO1998006430A1 Vaccines, antibodies, proteins, glycoproteins, dnas and rnas for prophylaxis and treatment of cryptosporidium parvum infections |
| 02/19/1998 | WO1998006429A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | WO1998006427A2 Cross-protective equine herpesvirus preparations and method of making and using the same |
| 02/19/1998 | WO1998006416A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
| 02/19/1998 | WO1998006408A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | WO1998006248A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
| 02/19/1998 | WO1997049805A3 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 02/19/1998 | WO1997049423A3 Liposomal influenza vaccine composition and method |
| 02/19/1998 | WO1997044451A3 Vasoactive amine binding molecules |
| 02/19/1998 | WO1997044356A3 Ret ligand (retl) for stimulating neural and renal growth |
| 02/19/1998 | DE19632862A1 Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe Immunologically active proteins of Borrelia burgdorferi, nucleic acids coding therefor and the use thereof in test kits and as vaccines |
| 02/19/1998 | CA2263730A1 Delivery of tolerogenic antigens via edible plants or plant-derived products |
| 02/19/1998 | CA2263316A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | CA2263219A1 Methods and means for modifying complement activation |
| 02/19/1998 | CA2263172A1 Two human nsp-like proteins |
| 02/19/1998 | CA2262748A1 Defining epitopes of the outer membrane protein copb of moraxella catarrhalis |
| 02/19/1998 | CA2262524A1 Gnrh-leukotoxin chimeras |
| 02/19/1998 | CA2262432A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | CA2262427A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
| 02/19/1998 | CA2261572A1 Lysyl oxidase synthetic polynucleotides |
| 02/18/1998 | EP0823913A1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 02/18/1998 | CN1173878A Bifunctional or bivalent antibody fragment analogue |
| 02/18/1998 | CN1173877A Novel membrane proteins of helicobacter pylori |
| 02/18/1998 | CN1173876A Novel membrane proteine P76 of helicobacter pylori |
| 02/18/1998 | CN1173540A Live attenuated RTX-producing bacteria of family pasteurellaceae |
| 02/18/1998 | CN1173500A PEG-interferon conjugates |
| 02/18/1998 | CN1173288A Milk powder containing specific immunity globulin and its prodn. method |
| 02/17/1998 | US5719269 For affinity separations of immunoglobulins |
| 02/17/1998 | US5719267 Clostridial toxin disease therapy |
| 02/17/1998 | US5719054 Recombinant virus vectors encoding human papillomavirus proteins |
| 02/17/1998 | US5719051 Tick borne encephalitis |
| 02/17/1998 | US5719049 Process for purifying hepatitis A virus (HAV), virus thus purified and vaccine compositions containing it |
| 02/17/1998 | US5718904 Adjuvant consisting of squalene, glycerol, surfactant |
| 02/17/1998 | US5718903 Veterinary medicine; stable transposon mutant |